BRYNJELSEN SEAN 4
4 · Eton Pharmaceuticals, Inc. · Filed Jun 5, 2025
Insider Transaction Report
Form 4
BRYNJELSEN SEAN
DirectorPresident & CEO10% Owner
Transactions
- Sale
Common Stock
2025-06-03$19.02/sh−400$7,608→ 3,013,513 total - Sale
Common Stock
2025-06-04$17.00/sh−70,000$1,190,000→ 2,943,513 total - Sale
Common Stock
2025-06-05$16.81/sh−70,000$1,176,700→ 2,873,513 total - Sale
Common Stock
2025-06-03$17.38/sh−60,945$1,059,224→ 3,022,568 total - Sale
Common Stock
2025-06-03$18.38/sh−8,655$159,079→ 3,013,913 total
Footnotes (6)
- [F1]The shares were sold in multiple trades at prices ranging from $17.00 to $17.88. The price reported above reflects the weighted average sales price.
- [F2]The shares were sold in multiple trades at prices ranging from $18.15 to $18.85. The price reported above reflects the weighted average sales price.
- [F3]The shares were sold in multiple trades at a price of $19.02.
- [F4]The shares were sold in multiple trades at prices ranging from $16.86 to $17.20. The price reported above reflects the weighted average sales price.
- [F5]The shares were sold in multiple trades at prices ranging from $16.62 to $17.15. The price reported above reflects the weighted average sales price.
- [F6]The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.